PSTV

#3618
PLUS THERAPEUTICS, Inc. Common Stock
0.30
0.00%
Sector:
Base:
Profit Currency:
Daily Range
0.30
0.30
Year Range
0.16
2.29
Daily Change
0.00%
Monthly Change
+25.00%
6 month change
-40.00%
Year Change
-55.88%
Previous Close
0.30
Open
0.30
Bid
Ask
Low
0.30
High
0.30
Volume
7
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

News